Oblimersen
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Oblimersen, covering 2012-08-16 to 2019-10-17. Get the full timeline:
Most recent: Clinical Trial Update: Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]